In the Lab
By Jim Stallard, MA, Writer/Editor | Thursday, September 6, 2012
Memorial Sloan-Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.
By Memorial Sloan-Kettering | Wednesday, September 5, 2012
Internationally recognized physician-scientist José Baselga has been named Physician-in-Chief of Memorial Hospital. He joins Memorial Sloan-Kettering from Massachusetts General Hospital.
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor | Tuesday, September 4, 2012
In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.
By Memorial Sloan-Kettering | Friday, August 31, 2012
Enzalutamide, a targeted therapy co-invented by a Memorial Sloan-Kettering investigator, has received FDA approval for the treatment of men with metastatic prostate cancer.
By Allyson Collins, MS, Science Writer/Editor | Thursday, August 30, 2012
In an interview, experts on our Adult Bone Marrow Transplantation Service talk about the types of transplantation and finding an appropriate donor for an allogeneic transplant.
By Memorial Sloan-Kettering | Wednesday, August 29, 2012
We recently launched our first-ever television advertising campaign, which offers a sense of the passion and compassion that defines how we care for people with cancer.
By Memorial Sloan-Kettering | Tuesday, August 28, 2012
Dr. Finley, Co-Director of the Complex Airway Program, explains how he lays out a treatment plan with his patients, and determines which type of surgery fits best in the context of their lifestyle.
In the Lab
By Media Staff | Friday, August 24, 2012
A new Memorial Sloan-Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.
By Memorial Sloan-Kettering | Tuesday, August 21, 2012
Dr. D’Angelica – who treats patients with liver, pancreatic, and bile duct cancers – discusses the expertise of Memorial Sloan-Kettering surgeons, who routinely perform complex procedures.
In the Lab
By Jim Stallard, MA, Writer/Editor | Friday, August 17, 2012
Memorial Sloan-Kettering investigators have found that some testicular cancers arising early in life may result from genetic changes that have not been inherited from either parent.
By Memorial Sloan-Kettering | Thursday, August 16, 2012
We have experts in all disciplines vital to treating esophageal cancer, and can provide therapies for people at any stage of the disease, from precancerous lesions to metastatic cancer.
By Memorial Sloan-Kettering | Wednesday, August 15, 2012
Dr. King talks about her research investigating why certain women develop breast cancer and about the long-term relationships she maintains with her patients.
By Allyson Collins, MS, Science Writer/Editor | Thursday, August 9, 2012
We encourage Facebook users to explore surgeon bios, videos of our experts, and cancer care information on our new tab.
By Memorial Sloan-Kettering | Wednesday, August 8, 2012
Dr. Mehrara talks about the expertise of Memorial Sloan-Kettering plastic surgeons and how patients with breast cancer and head and neck cancer benefit from recent advances in reconstructive surgery.
By Memorial Sloan-Kettering | Tuesday, August 7, 2012
When 45-year-old Jane learned she had a tumor in her ovary, she came to Memorial Sloan-Kettering for surgery and chemotherapy.